Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit.

P MihalovJ HodosyA KoščálováM ČaprndaM KachlíkováJ JurenkaM BendžalaPeter Sabaka

Published in: The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale (2023)

Prior exposure to ceftriaxone increases the risk of MDR-Ab infection in COVID-19 patients admitted to the ICU. Our findings suggest that antibiotic use in COVID-19 patients admitted to the ICU should be restricted to patients with documented bacterial superinfection.

Keyphrases

coronavirus disease
sars cov
multidrug resistant
intensive care unit
acinetobacter baumannii
risk factors
drug resistant
mechanical ventilation
staphylococcus aureus
mesenchymal stem cells
bone marrow
acute respiratory distress syndrome
replacement therapy